Akero Therapeutics Inc (NAS:AKRO)
$ 20.3552 0.2152 (1.07%) Market Cap: 1.41 Bil Enterprise Value: 525.23 Mil PE Ratio: 0 PB Ratio: 1.66 GF Score: 41/100
Back to the Transcripts List

Akero Therapeutics Inc at Bank of America Healthcare Conference Transcript

May 11, 2022 / 03:40PM GMT
Release Date Price: $8.77 (-12.30%)
Dan Lundquist
BofA Securities, Inc. - Analyst

Hi, my name is Dan Lundquist. Thank you very much for joining the Wednesday events. I'm the healthcare specialist to BofA and very pleased to welcome with me today Kitty Yale from Akero. She's the Chief Development Officer. She does have some presentation slides, so she'll go through those. And then if we have some time, we have some Q&A as well.

All right. Thank you, Kitty.

Kitty Yale
Akero Therapeutics, Inc. - Chief Development Officer

Thank you. So good morning, everybody. As Dan said, I am Kitty Yale. I am the Chief Development Officer at Akero. And Akero is developing Efruxifermin or for short, we describe it as EFX as a potential best-in-class NASH therapy.

An EFX is a differentiated Fc-FGF21 fusion protein that's been engineered to mimic the balanced biological activity of native FGF21.

The data I am going to share with you today is from our Phase 2a program. And we are pleased that some of the data that we generated in our Phase 2 program is some of the strongest of

Already have an account? Log in
Get the full story
Start 7-Day Free Trial
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.